Prostate cancer treatment that involves less overall radiotherapy, which is delivered in stronger but fewer dosages, has been deemed safe.
The work conducted at the Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust examined a total of 457 men with the disease. Doctors found that the higher concentration of radiation had the same affect on sexual function, the bowel and the bladder as the existing treatment methods.
Scientist explained that the results are important as earlier research has suggested that prostate tumours could be more effectively treated with the stronger dosages.
Dr Emma Hall from the ICR's Clinical Trials and Statistics Unit said: "The finding that this treatment schedule is as safe as standard treatment has allowed us to expand the trial to include men from all over the UK."
According to Cancer Research UK, prostate cancer is the most common form of the disease among men in the UK.